Jan Linder

4.0k total citations · 1 hit paper
67 papers, 3.0k citations indexed

About

Jan Linder is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jan Linder has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Neurology, 18 papers in Physiology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jan Linder's work include Parkinson's Disease Mechanisms and Treatments (44 papers), Neurological disorders and treatments (39 papers) and Voice and Speech Disorders (10 papers). Jan Linder is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (44 papers), Neurological disorders and treatments (39 papers) and Voice and Speech Disorders (10 papers). Jan Linder collaborates with scholars based in Sweden, United Kingdom and United States. Jan Linder's co-authors include Lars Forsgren, Anders Bill, Hans Stenlund, Kaj Blennow, Henrik Zetterberg, Magnus Domellöf, Katrine Riklund, Patric Blomstedt, Eva Elgh and David Bäckström and has published in prestigious journals such as PLoS ONE, Brain and The Science of The Total Environment.

In The Last Decade

Jan Linder

67 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blood-based NfL

2017 356 citations Oskar Hansson, Shorena Janelidze et al. Neurology profile →

Peers

Countries citing papers authored by Jan Linder

Since Specialization

Citations

This map shows the geographic impact of Jan Linder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Linder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Linder more than expected).

Fields of papers citing papers by Jan Linder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Linder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Linder. The network helps show where Jan Linder may publish in the future.

Co-authorship network of co-authors of Jan Linder

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Linder. A scholar is included among the top collaborators of Jan Linder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Linder. Jan Linder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood-based NfL breakdown → 2017 ·Neurology ·Oskar Hansson, Shorena Janelidze, Sara Hall, Nadia Magdalinou, Andrew J. Lees, Ulf Andréasson, Niklas Norgren, Jan Linder, Lars Forsgren, Radu Constantinescu, Henrik Zetterberg, Kaj Blennow, (unknown)	356
2	PITX3 genotype and risk of dementia in Parkinson's disease: A population-based study 2017 ·Journal of the Neurological Sciences ·David Bäckström, Magnus Domellöf, Gabriel Granåsen, Jan Linder, Sofia Mayans, Eva Elgh, Susanna Jakobson Mo, Lars Forsgren	12
3	Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs 2016 ·Parkinsonism & Related Disorders ·Sven Pålhagen, Olof Sydow, Anders Johansson, Dag Nyholm, Björn Holmberg, Håkan Widner, Nil Dizdar, Jan Linder, (unknown), Rasmus Jansson‐Löfmark, Lars Bergmann, (unknown), Thomas S. Marshall	43
4	Neck Muscle Strain in Air Force Pilots Wearing Night Vision Goggles 2016 ·Aerospace Medicine and Human Performance ·(unknown), Riccardo LoMartire, Jan Linder, (unknown), Björn Äng	14
5	Validity and Responsiveness of At-Home Touch Screen Assessments in Advanced Parkinson's Disease 2015 ·IEEE Journal of Biomedical and Health Informatics ·Mevludin Memedi, Dag Nyholm, Anders Johansson, Sven Pålhagen, (unknown), Håkan Widner, Jan Linder, Jerker Westin	13
6	Weight gain and increased central obesity in the early phase of Parkinson's disease 2014 ·Clinical Nutrition ·(unknown), Maine Carlsson, Jan Linder, Lars Forsgren, Lena Håglin	61
7	Long Leukocyte Telomere Length at Diagnosis Is a Risk Factor for Dementia Progression in Idiopathic Parkinsonism 2014 ·PLoS ONE ·Sofie Degerman, Magnus Domellöf, Mattias Landfors, Jan Linder, (unknown), (unknown), Eva Elgh, Göran Roos, Lars Forsgren	26
8	No GGGGCC-hexanucleotide repeat expansion inC9ORF72in parkinsonism patients in Sweden 2012 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Chizuru Akimoto, Lars Forsgren, Jan Linder, Anna Birve, (unknown), (unknown), (unknown), (unknown), Peter M. Andersen	20
9	Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's Disease 2012 ·Journal of Parkinson s Disease ·Sok Kean Khoo, David Petillo, Un Jung Kang, James H. Resau, (unknown), Jan Linder, Lars Forsgren, (unknown), Aik Choon Tan	160
10	Control of phonatory onset and offset in Parkinson patients following deep brain stimulation of the subthalamic nucleus and caudal zona incerta 2012 ·Parkinsonism & Related Disorders ·Fredrik Karlsson, Patric Blomstedt, Katarina Olofsson, Jan Linder, Erik Nordh, Jan van Doorn	20
11	Deep brain stimulation of the subthalamic nucleus versus the zona incerta in the treatment of essential tremor 2011 ·Acta Neurochirurgica ·Patric Blomstedt, Ulrika Sandvik, Jan Linder, (unknown), Lars Forsgren, Marwan Hariz	44
12	Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism 2011 ·Journal of Neurology ·Jan Linder, Britt‐Inger Wenngren, Hans Stenlund, Lars Forsgren	14
13	Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study 2010 ·European Journal of Nuclear Medicine and Molecular Imaging ·Susanna Jakobson Mo, Jan Linder, Lars Forsgren, Anne Larsson, Lennart Johansson, Katrine Riklund	44
14	Reproducibility and influence of test modality order on thermal perception and thermal pain thresholds in quantitative sensory testing 2010 ·Clinical Neurophysiology ·(unknown), Jan Linder, (unknown), Erik Nordh	77
15	Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population‐based study 2010 ·Movement Disorders ·Jan Linder, Hans Stenlund, Lars Forsgren	101
16	Cognitive function in early Parkinson’s disease: a population‐based study 2009 ·European Journal of Neurology ·Eva Elgh, Magnus Domellöf, Jan Linder, Mona Edström, Hans Stenlund, (unknown)	177
17	Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort 2009 ·Journal of Neurology ·Jan Linder, Richard Birgander, (unknown), Katrine Riklund, (unknown), Mona Edström, Hans Stenlund, Lars Forsgren	15
18	Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory 2008 ·Brain ·Petter Marklund, Anne Larsson, Eva Elgh, Jan Linder, Katrine Riklund, Lars Forsgren, Lars Nyberg	59
19	Decreased Peripheral Glucocorticoid Sensitivity in Alzheimer’s Disease 1993 ·Gerontology ·Jan Linder, (unknown), Birgitta Näsman, Ove Bäck, A. Uddhammar, Tommy Olsson	27
20	Sympathetic Control of Cerebral Blood Flow in Acute Arterial Hypertension 1976 ·Acta Physiologica Scandinavica ·Anders Bill, Jan Linder	228

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact